Avinger, Inc (AVGR) News Headlines

▮ More

Date

Headline

4/10/2019 8:15:19 AM Avinger Receives FDA Clearance Of Pantheris SV Device

3/6/2019 4:14:00 PM Avinger Q4 Loss/share $0.31 Vs. Loss $12.58 Year Ago

12/19/2018 6:02:20 AM Avinger Announces Release Of Preliminary Analysis Of Results From Its SCAN Clinical Study

8/30/2018 8:32:50 AM Avinger Submits New 510(k) Application To FDA For Pantheris SV Lumivascular Atherectomy System

8/23/2018 8:35:00 AM Avinger Completes Enrollment In SCAN Clinical Study

7/12/2018 8:34:56 AM Avinger Announces Pricing Of $3.55 Mln Registered Direct Offering

7/10/2018 8:32:13 AM Avinger Appoints Jaafer Golzar As Chief Medical Officer

6/26/2018 9:50:59 PM SPHS Rebounds, ACHV Soars On New Data, PBYI Gains On CHMP Opinion, SPPI Abuzz

6/14/2018 8:31:33 AM Avinger Says First Patients Enrolled In Post-Market Study Comparing Pantheris OCT Imaging To Intravascular Ultrasound

5/23/2018 8:40:10 PM FDA Nod For AVGR, EOLS Is All Smiles, GERN Up 30% In 3 Days, IMMP On Watch

5/23/2018 8:33:50 AM Avinger Gets 510(k) Clearance From FDA For Next Generation Pantheris Lumivascular Atherectomy System

5/14/2018 4:34:33 PM Avinger Q1 Loss/share $5.37 Vs. Loss $25.74 Year Ago

5/1/2018 9:20:26 PM HTBX Up 265% In 2 Days, AVGR Heartened, SCPH Faces FDA In June, THC Healthy

3/29/2018 10:57:07 PM FOMX To Report Data In Q3, INNT Continues To Sizzle, All Eyes On GALT

3/29/2018 9:07:42 AM Avinger Reports First-in-Patient Use Of Extended Nosecone Version Of Next Generation Pantheris

3/20/2018 10:57:29 PM SLS To Report Data In 1H18, AVGR Slumps As Revenue Drops, DXR Down 45% In 3 Days

3/19/2018 4:02:47 PM Avinger Q4 Loss/share $12.58 Vs. Loss $23.35 Year Ago

3/2/2018 8:03:56 AM Avinger Regains Compliance With Nasdaq Listing Requirements

2/20/2018 8:36:24 PM VYGR Soars On Alzheimer's Deal, RARX Up 21% In 5 Days, ATXI Catches Eyes

2/14/2018 8:31:36 AM Avinger Announces Pricing Of $18 Mln Underwritten Public Offering